Smithfield Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.5M Sell
79,869
-251
-0.3% -$58.5K 0.85% 25
2025
Q4
$16.6M Buy
80,120
+638
+0.8% +$126K 0.73% 28
2025
Q3
$14.7M Sell
79,482
-174
-0.2% -$29.8K 0.66% 31
2025
Q2
$12.2M Sell
79,656
-558
-0.7% -$85.8K 0.58% 36
2025
Q1
$13.3M Sell
80,214
-4,303
-5% -$673K 0.67% 31
2024
Q4
$12.2M Sell
84,517
-1,973
-2% -$306K 0.61% 32
2024
Q3
$14M Buy
86,490
+4,274
+5% +$681K 0.69% 30
2024
Q2
$12M Sell
82,216
-1,003
-1% -$149K 0.63% 32
2024
Q1
$13.2M Sell
83,219
-2,655
-3% -$423K 0.7% 32
2023
Q4
$13.5M Sell
85,874
-1,720
-2% -$264K 0.76% 29
2023
Q3
$13.7M Sell
87,594
-49
-0.1% -$8.09K 0.84% 27
2023
Q2
$14.5M Sell
87,643
-1,029
-1% -$166K 0.88% 25
2023
Q1
$13.8M Sell
88,672
-605
-0.7% -$97.7K 0.88% 24
2022
Q4
$15.8M Sell
89,277
-771
-0.9% -$133K 1.06% 21
2022
Q3
$14.7M Sell
90,048
-686
-0.8% -$116K 1.06% 20
2022
Q2
$16.1M Buy
90,734
+50
+0.1% +$8.91K 1.13% 19
2022
Q1
$16.1M Buy
90,684
+183
+0.2% +$31.1K 1.04% 18
2021
Q4
$15.5M Sell
90,501
-1,321
-1% -$216K 0.96% 20
2021
Q3
$14.8M Sell
91,822
-38
-0% -$6.48K 0.98% 17
2021
Q2
$15.1M Buy
91,860
+279
+0.3% +$46.2K 1% 18
2021
Q1
$15.1M Sell
91,581
-290
-0.3% -$46.9K 1.04% 17
2020
Q4
$14.5M Sell
91,871
-597
-0.6% -$88.1K 1.05% 18
2020
Q3
$13.8M Buy
92,468
+10,988
+13% +$1.63M 1.12% 19
2020
Q2
$11.5M Buy
81,480
+1,233
+2% +$180K 1.03% 20
2020
Q1
$10.5M Sell
80,247
-2,847
-3% -$404K 1.1% 19
2019
Q4
$12.1M Sell
83,094
-2,790
-3% -$378K 1.13% 20
2019
Q3
$11.1M Buy
85,884
+22
+0% +$2.9K 1.1% 20
2019
Q2
$12M Buy
85,862
+5,367
+7% +$743K 1.24% 18
2019
Q1
$11.3M Sell
80,495
-1,696
-2% -$227K 1.22% 17
2018
Q4
$10.6M Buy
82,191
+1,840
+2% +$257K 1.24% 18
2018
Q3
$11.1M Buy
80,351
+89
+0.1% +$11.8K 1.2% 19
2018
Q2
$9.74M Buy
80,262
+10,655
+15% +$1.33M 1.12% 18
2018
Q1
$8.92M Buy
69,607
+202
+0.3% +$27.3K 1.08% 19
2017
Q4
$9.7M Buy
69,405
+7,068
+11% +$985K 1.18% 18
2017
Q3
$8.1M Buy
62,337
+299
+0.5% +$39.6K 1.1% 20
2017
Q2
$8.21M Sell
62,038
-454
-0.7% -$57.9K 1.2% 17
2017
Q1
$7.78M Sell
62,492
-1,460
-2% -$174K 1.22% 19
2016
Q4
$7.37M Sell
63,952
-63
-0.1% -$7.28K 1.24% 19
2016
Q3
$7.56M Buy
64,015
+1,556
+2% +$189K 1.35% 16
2016
Q2
$7.58M Buy
62,459
+3,693
+6% +$420K 1.42% 15
2016
Q1
$6.36M Buy
58,766
+7,014
+14% +$726K 1.24% 20
2015
Q4
$5.32M Sell
51,752
-704
-1% -$70.8K 1.1% 20
2015
Q3
$4.9M Buy
52,456
+530
+1% +$51.3K 1.04% 21
2015
Q2
$5.06M Sell
51,926
-1,607
-3% -$161K 1% 21
2015
Q1
$5.38M Sell
53,533
-732
-1% -$74.4K 1.06% 21
2014
Q4
$5.67M Sell
54,265
-6,506
-11% -$686K 1.17% 18
2014
Q3
$6.48M Sell
60,771
-1,830
-3% -$190K 1.31% 15
2014
Q2
$6.55M Sell
62,601
-10,468
-14% -$1.06M 1.29% 14
2014
Q1
$7.18M Sell
73,069
-5,033
-6% -$467K 1.43% 14
2013
Q4
$7.15M Buy
78,102
+21,736
+39% +$2M 1.45% 14
2013
Q3
$4.89M Sell
56,366
-77
-0.1% -$6.91K 1.12% 17
2013
Q2
$4.85M Buy
+56,443
New +$4.79M 1.16% 16

Other funds holding JNJ

Smithfield Trust's JNJ Position: Q1 2026 in Review

Smithfield Trust reduced its Johnson & Johnson (JNJ) stake by 0.31% in Q1 2026, selling an estimated $58.5K and leaving 79,869 shares worth $19.5M. The position accounts for 0.85% of the portfolio, ranked #25.

Smithfield Trust first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Smithfield Trust held 79,869 shares of Johnson & Johnson worth $19.5M as of Q1 2026.
  • Smithfield Trust sold 251 Johnson & Johnson shares in Q1 2026, an estimated $58.5K.
  • Johnson & Johnson made up 0.85% of Smithfield Trust's portfolio in Q1 2026, its #25 holding.
  • Smithfield Trust first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.